人类抗体对Omicron亚系的广泛中和和XBB变异的逃避的结构基础
Hui Sun1, Yizhen Wang1, Xiuting Chen1
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, School of Life Sciences, Xiamen University , Xiamen, China.
像Omicron XBB这样的新型SARS-CoV-2变种逃避中和抗体,降低了疫苗的有效性. 这项研究结构性地解释了如何通过这些新兴变体绕过3类中和抗体.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 随着COVID-19大流行,SARS-CoV-2变种的不断出现.
- 奥米克朗XBB亚系表现出高传染性和对中和抗体的显著抵抗力.
- 这种抗体耐药性损害了疫苗的有效性,导致突破和再感染.
研究的目的:
- 提供全面的结构理解,即新出现的SARS-CoV-2变种如何逃避3类中和抗体.
- 阐明Omicron XBB亚系对免疫规避的机制.
主要方法:
- 结构分析3类中和抗体 (例如,1G11,LY-CoV1404) 与新兴变种的SARS-CoV-2尖端蛋白复合.
- 进行比较性结构比较,以确定负责抗体逃避的关键突变.
主要成果:
- 新出现的SARS-CoV-2变种具有突变,可显著改变由3类中和抗体识别的表位.
- 结构数据揭示了尖端蛋白的特定构造变化,这些变化阻碍了抗体结合和中和.
- 以前有效的治疗抗体由于结构逃避,对这些变体的活性降低或消除.
结论:
- 3类中和抗体,包括1G11和LY-CoV1404,对目前流传的SARS-CoV-2变体大致无效.
- 了解抗体逃避的结构基础对于开发下一代疫苗和治疗方法至关重要.
- 这些发现凸显了对广泛保护性抗体或替代治疗策略的需要,以对抗不断演变的SARS-CoV-2.
更多相关视频
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
相关概念视频
Cross-reactivity
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
